Integra LifeSciences Corporation
IART | NASDAQ
$16.03
+$0.44 (+2.82%)
Sep 22, 2026, 12:52 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.65B | 1.64B | 1.64B | 1.64B | 1.62B | 1.62B | 1.61B | 1.56B | 1.57B | 1.53B | 1.54B | 1.54B | 1.55B | 1.56B | 1.56B | 1.57B | 1.57B | 1.56B | 1.54B | 1.53B | 1.51B | 1.38B |
Cost of Revenue | 762.22M | 769.47M | 790.01M | 764.02M | 768.66M | 754.65M | 728.47M | 705.44M | 688.92M | 670.9M | 656.84M | 634.23M | 618.6M | 592.76M | 587.36M | 595.67M | 591.69M | 594.55M | 597.81M | 588.63M | 578.97M | 533.18M |
Gross Profit | 885.45M | 875.04M | 845.23M | 878.94M | 853.07M | 869.66M | 882.06M | 859.48M | 877.59M | 858.7M | 884.74M | 908.33M | 926.73M | 969.11M | 970.31M | 969.5M | 975.15M | 964.46M | 944.64M | 936.94M | 929.97M | 844.43M |
Operating Income | 655.86M | 123.9M | 68.32M | -452.25M | -500.69M | 8.95M | 28.41M | 28.83M | 63.58M | 79.11M | 111.53M | 143.32M | 181.78M | 229.14M | 238.92M | 229.3M | 220.69M | 212.68M | 197.23M | 191.65M | 192.76M | 154.98M |
Interest Income | 14.64M | 15.08M | 15.84M | 16.37M | 16.44M | 16.79M | 20.04M | 19.7M | 19.25M | 18.14M | 17.2M | 17.96M | 16.62M | 14.65M | 11.92M | 8.05M | 6.57M | 6.37M | 6.74M | 7.47M | 7.96M | 8.48M |
Pretax Income | -179K | -535.88M | -563.5M | -545.27M | -558.81M | -43.04M | -18.24M | -11.92M | 27.05M | 46.06M | 81.07M | 116.42M | 156.61M | 204.36M | 213.89M | 201.47M | 193.47M | 186.71M | 214.68M | 201.81M | 192.53M | 149.36M |
Net Income | -7.24M | -495.8M | -516.47M | -495.34M | -500.63M | -28.96M | -6.94M | -6.54M | 23.65M | 40.23M | 67.74M | 100.85M | 131.27M | 171.88M | 180.55M | 172.99M | 166.3M | 156.58M | 169.08M | 216.44M | 205.54M | 170.11M |
Selling & General & Admin | 688.98M | 696.44M | 699.7M | 708.95M | 717.1M | 732.68M | 716.98M | 701.59M | 686.35M | 655.78M | 656.64M | 645.43M | 627.3M | 623.05M | 616.32M | 626.65M | 638.84M | 640.74M | 637.45M | 637.59M | 631.65M | 585.21M |
Research & Development | 95M | 97.75M | 98.97M | 105.39M | 110.37M | 113.14M | 115.38M | 108.45M | 107.61M | 104.43M | 104.19M | 106.69M | 104.83M | 103.83M | 101.19M | 99.14M | 100.23M | 94.76M | 93.05M | 90.51M | 84.13M | 78.94M |
Other Expenses | -554.39M | -43.04M | -21.76M | 516.85M | 526.3M | 14.89M | 21.29M | 20.61M | 20.06M | 19.38M | 12.38M | 12.89M | 12.82M | 13.1M | 13.88M | 14.76M | 16.6M | 18.33M | 19.31M | 19.25M | 22.61M | 25.65M |
Operating Expenses | 229.59M | 751.14M | 776.92M | 1.33B | 1.35B | 860.71M | 853.65M | 830.65M | 814.01M | 779.59M | 773.21M | 765.01M | 744.95M | 739.98M | 731.39M | 740.2M | 754.45M | 751.78M | 747.41M | 745.29M | 737.22M | 689.45M |
Interest Expense | 96.24M | 94.29M | 87.68M | 82.99M | 79.64M | 77.25M | 70.63M | 65.4M | 59.09M | 52.9M | 51.38M | 50.52M | 50.27M | 50.04M | 49.59M | 48.83M | 48.21M | 49.12M | 50.4M | 55.62M | 64.23M | 66.76M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 991.81M | 1.52B | 1.57B | 2.1B | 2.12B | 1.62B | 1.58B | 1.54B | 1.5B | 1.45B | 1.43B | 1.4B | 1.36B | 1.33B | 1.32B | 1.34B | 1.35B | 1.35B | 1.35B | 1.33B | 1.32B | 1.22B |
Income Tax Expense | 7.06M | -40.08M | -47.03M | -49.94M | -58.18M | -14.09M | -11.29M | -5.38M | 3.4M | 5.83M | 13.33M | 15.57M | 25.34M | 32.48M | 33.34M | 28.49M | 27.16M | 30.13M | 45.6M | -14.63M | -13.01M | -20.75M |
Shares Outstanding (Basic) | 78.17M | 76.95M | 76.75M | 76.75M | 76.46M | 76.46M | 77.01M | 76.45M | 77.41M | 77.74M | 78.33M | 79.69M | 80.97M | 81.87M | 83.65M | 83.04M | 83.17M | 83.63M | 84.7M | 84.75M | 84.69M | 84.5M |
Shares Outstanding (Diluted) | 78.17M | 76.95M | 76.75M | 76.75M | 76.46M | 76.46M | 77.01M | 76.45M | 77.41M | 77.74M | 78.33M | 79.81M | 81.15M | 82.32M | 83.65M | 83.4M | 83.62M | 84.28M | 85.78M | 85.45M | 85.34M | 85.26M |
EPS (Basic) | -0.09 | -6.48 | -6.75 | -6.48 | -6.55 | -0.38 | -0.09 | -0.09 | 0.29 | 0.50 | 0.84 | 1.22 | 1.58 | 2.07 | 2.16 | 2.07 | 1.98 | 1.85 | 2 | 2.56 | 2.43 | 2.02 |
EPS (Diluted) | -0.09 | -6.48 | -6.75 | -6.48 | -6.55 | -0.38 | -0.09 | -0.09 | 0.29 | 0.50 | 0.83 | 1.21 | 1.57 | 2.06 | 2.16 | 2.06 | 1.97 | 1.84 | 1.98 | 2.54 | 2.41 | 2 |
EBITDA | 210.66M | -289.3M | -326.2M | -313.07M | -332.17M | 180.3M | 193.29M | 187.77M | 215.03M | 221.9M | 257.22M | 287.75M | 328.24M | 375.96M | 377.14M | 362.91M | 348.43M | 336.5M | 366.28M | 358.83M | 363.93M | 328.03M |
EBIT | 96.06M | -441.59M | -477.25M | -463.71M | -480.6M | 32.78M | 52.4M | 53.48M | 86.14M | 98.96M | 132.45M | 164.47M | 204.4M | 251.93M | 255.8M | 239.64M | 225.58M | 213.92M | 242.66M | 240.47M | 245.23M | 210.41M |
Depreciation & Amortization | 114.6M | 152.29M | 151.05M | 150.53M | 148.33M | 147.42M | 140.8M | 134.29M | 128.89M | 122.94M | 124.77M | 123.28M | 123.84M | 124.03M | 121.34M | 123.27M | 122.85M | 122.59M | 123.62M | 118.37M | 118.7M | 117.62M |
Add to Watchlist
Select watchlists to add or remove IART